ERBB2 and breast carcinoma: In agreement with previous findings [25], these cells share high TIMP-1 expression compared with the BT-474 epithelial breast cancer cell line (ER+, PR+, HER2 over-expression), with MDA-MB-231 displaying higher levels than BT-549 cells (Figure 1A).